Raloxifene is the generic name for an osteoporosis medicine with the brand name Evista®, a product of Eli Lilly and Company. No generic version of Evista is available. The patent for Evista is valid until March of 2014; however, other circumstances, such as lawsuits, could delay this.  Refer to Evista entry for information about this… Read more

Reclast® is a prescription medicine option for treatment of osteoporosis manufactured by Novartis. Reclast is in the class of medicines called bisphosphonates that also includes Actonel, generic alendronate, Atelvia, Boniva, Fosamax, and generic ibandronate. Reclast works by decreasing the rate that bone is broken down. This reduction in bone turnover results in stabilizing or building… Read more

Bone is constantly changing. Old bone breaks down and new bone is formed in a continuous process called remodeling. The bone breakdown cells, osteoclasts are linked with the bone forming cells, osteoblasts in a cycle of bone breakdown and formation. Remodeling occurs in sequence initiated by microdamage to start the repair process. In remodeling, bone… Read more

Risedronate is the generic name for an osteoporosis medicine with brand names Actonel® and Atelvia®, products of Warner Chilcott. No generic versions of Actonel or Atelvia are available since the patents are still in effect. Actonel is slated to go off patent in 2013; however, other circumstances, such as lawsuits, could delay this.  Refer to… Read more

The list of risk factors for osteoporosis and fractures is long and extensive. Some you can modify others like your age you can’t. Rather than listing innumerable risk factors, the most common are included below. What You Can’t Change Older age Being a woman Family history of fractures or osteoporosis Race – White or Asian… Read more